Abstract:The interaction of iron and oxygen is an integral part of the development of life on Earth. Nonetheless, this unique chemistry continues to fascinate and puzzle, leading to new biological ventures. In 2012, a Columbia University group recognized this interaction as a central event leading to a new type of regulated cell death named "ferroptosis." The major feature of ferroptosis is the accumulation of lipid hydroperoxides due to (1) dysfunctional antioxidant defense and/or (2) overwhelming oxidative stress, which most frequently coincides with increased content of free labile iron in the cell. This is normally prevented by the canonical anti-ferroptotic axis comprising the cystine transporter xCT, glutathione (GSH), and GSH peroxidase 4 (GPx4). Since ferroptosis is not a programmed type of cell death, it does not involve signaling pathways characteristic of apoptosis. The most common way to prove this type of cell death is by using lipophilic antioxidants (vitamin E, ferrostatin-1, etc.) to prevent it. These molecules can approach and detoxify oxidative damage in the plasma membrane. Another important aspect in revealing the ferroptotic phenotype is detecting the preceding accumulation of lipid hydroperoxides, for which the specific dye BODIPY C11 is used. The present manuscript will show how ferroptosis can be induced in wild-type medulloblastoma cells by using different inducers: erastin, RSL3, and iron-donor. Similarly, the xCT-KO cells that grow in the presence of NAC, and which undergo ferroptosis once NAC is removed, will be used. The characteristic "bubbling" phenotype is visible under the light microscope within 12-16 h from the moment of ferroptosis triggering. Furthermore, BODIPY C11 staining followed by FACS analysis to show the accumulation of lipid hydroperoxides and consequent cell death using the PI staining method will be used. To prove the ferroptotic nature of cell death, ferrostatin-1 will be used as a specific ferroptosis-preventing agent.

Connecting the Dots in the Neuroglobin-Protein Interaction Network of an Unstressed and Ferroptotic Cell Death Neuroblastoma Model

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic pathway of cell death

Neuroglobin Promotes Neurite Outgrowth Via Differential Binding to PTEN and Akt

Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons.

Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury.

Effect of neuroglobin on oxygen-glucose deprivation and reoxygenation induced autophagy in a human neuroblastoma cell line

Overexpression of Neuroglobin Promotes Energy Metabolism and Autophagy Induction in Human Neuroblastoma SH-SY5Y Cells

[The Role of Neuroglobin in Oxygen-Glucose Deprivation and Reoxygenation-Induced Mitochondrial Depolarization and Reactive Oxygen Species Production in SH-SY5Y Cells].

Impaired hypoxic tolerance in APP23 mice: a dysregulation of neuroprotective globin levels

Revealing the Ferroptotic Phenotype of Medulloblastoma

Neuroglobin Facilitates Neuronal Oxygenation through Tropic Migration under Hypoxia or Anemia in Rat: How Does the Brain Breathe?

Neuroglobin, a Novel Target for Endogenous Neuroprotection Against Stroke and Neurodegenerative Disorders.

Neuroglobin protects dopaminergic neurons in a Parkinson's cell model by interacting with mitochondrial complex NDUFA10

Neuroprotection of overexpression of neuroglobin gene on injury of SH-SY5Y cells and relevant mechanism

Microglial ferroptotic stress causes non-cell autonomous neuronal death

The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease

ADP-ribose triggers neuronal ferroptosis via metabolic orchestrating

NFE2L1-mediated proteasome function protects from ferroptosis

Effects of Neuroglobin Overexpression on Acute Brain Injury and Long-Term Outcomes after Focal Cerebral Ischemia.

Neuroglobin Attenuates Beta Amyloid-Induced Apoptosis Through Inhibiting Caspases Activity by Activating PI3K/Akt Signaling Pathway